======= HMGB3 ======= == Gene Information == * **Official Symbol**: HMGB3 * **Official Name**: high mobility group box 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3149|3149]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15347|O15347]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HMGB3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HMGB3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300193|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of a family of proteins containing one or more high mobility group DNA-binding motifs. The encoded protein plays an important role in maintaining stem cell populations, and may be aberrantly expressed in tumor cells. A mutation in this gene was associated with microphthalmia, syndromic 13. There are numerous pseudogenes of this gene on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]. * **UniProt Summary**: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. Associates with chromatin and binds DNA with a preference to non- canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor (By similarity). Negatively regulates B-cell and myeloid cell differentiation. In hematopoietic stem cells may regulate the balance between self-renewal and differentiation. Involved in negative regulation of canonical Wnt signaling (By similarity). {ECO:0000250|UniProtKB:O54879, ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P40618}. |HMG box| |negative regulation of B cell differentiation| |four-way junction DNA binding| |DNA binding, bending| |regulation of B cell differentiation| |negative regulation of B cell activation| |negative regulation of lymphocyte differentiation| |negative regulation of myeloid cell differentiation| |negative regulation of leukocyte differentiation| |double-stranded DNA binding| |DNA geometric change| |negative regulation of hemopoiesis| |negative regulation of lymphocyte activation| |chromatin remodeling| |regulation of lymphocyte differentiation| |negative regulation of leukocyte activation| |negative regulation of cell activation| |regulation of B cell activation| |DNA recombination| |regulation of myeloid cell differentiation| |nuclear chromatin| |regulation of leukocyte differentiation| |DNA conformation change| |transcription factor binding| |positive regulation of innate immune response| |positive regulation of response to biotic stimulus| |negative regulation of immune system process| |regulation of hemopoiesis| |regulation of innate immune response| |positive regulation of defense response| |positive regulation of multi-organism process| |regulation of lymphocyte activation| |regulation of response to biotic stimulus| |positive regulation of response to external stimulus| |regulation of leukocyte activation| |regulation of cell activation| |chromatin organization| |negative regulation of cell differentiation| |DNA metabolic process| |regulation of defense response| |innate immune response| |regulation of multi-organism process| |positive regulation of immune response| |negative regulation of developmental process| |defense response to other organism| |chromosome organization| |regulation of response to external stimulus| |regulation of immune response| |positive regulation of immune system process| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |RNA binding| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.12| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.97| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.91| |[[:results:exp292|Menadione 5μM R06 exp292]]|-1.89| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.7| |[[:results:exp136|MS094 2μM R03 exp136]]|1.94| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.513| Global Fraction of Cell Lines Where Essential: 0/683 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/25| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/14| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13140 * **Expression level (log2 read counts)**: 6.61 {{:chemogenomics:nalm6 dist.png?nolink |}}